Download - A1 Strategic Memo Final
-
7/23/2019 A1 Strategic Memo Final
1/13
S
U
-
7/23/2019 A1 Strategic Memo Final
2/13
CONTENTS
INTRODUCTION...........................................................................................................................1
ACQUISITION AND JOINT VENTURES....................................................................................2
SWOT ANALYSIS..........................................................................................................................3
FRED DAVID TOW MATRIX....................................................................................................4
DIVERSIFIED REVENUE BASE..................................................................................................5
FINANCIAL ANALYSIS OF MERGED ENTITY........................................................................5
SUN PHARMATACTICS AND STRATEGY...............................................................................!
LEADERSHIP TEAM....................................................................................................................."
DIAMOND STRATEGY APPLIED TO SUN PHARMA..............................................................#QSPM TOOL FOR DECISION MA$ING.....................................................................................#
TARNISHED BRAND IMAGE ISSUE OF RANBAXY...............................................................%
FUTURE STRATEGY& REMEDIAL ACTIONS..........................................................................1'
REFERENCES..............................................................................................................................1'
-
7/23/2019 A1 Strategic Memo Final
3/13
ABSTRACT
T()* +,-+/ -+0),* /(, ,/), *)* 67/ 897)*)/) : R6; 6 S7 P(+)8 :)/ ) S7 P(+
-
7/23/2019 A1 Strategic Memo Final
4/13
INTRODUCTIONS7 P(+,,+)8+=)> / C +=/( +)0,+*. S,0,+ :8/+* )?, ,8+=/( ,+-()88(>,* /+*)/) ) 8)/ >+=/( ) /(, -(+)> 1
-
7/23/2019 A1 Strategic Memo Final
5/13
ACQUISITION AND JOINT VENTURES
S7 P(+
-
7/23/2019 A1 Strategic Memo Final
6/13
STRENGTHS
KD., +.=/( -./,4/)23 )4 I41)2
THREATS
KS/+)4>,4/G.0,+4732/).4*
KP+.178/L)26)3)/5C32)/(* / /?,0/>, : --+/7)/),*1. U*, */+> )*/+)67/)
,/=+? :+ *,* ) ,)>>+=/( -/,/).
Opportunity-Weaness (OW)
Strategies
O0,+8 0/>, :--+/7)/),*
1. U*, 6+ -+/:) /+,** ,:,8/*.2. P/,/ -+78/* ) ,)>,/ G0,+7/)*
2. P+78/ L)6))/ C) )*/+)67/) /0,+8*.
-
7/23/2019 A1 Strategic Memo Final
7/13
DIVERSIFIED REVENUE BASE
Pre Ran!a"y A#$uisition Post Ran!a"y A#$uisition
2#$
1%$&$
%'$
2$
Sales(in s *illions)
S ene"ics ndian
ene"ics
#e"in
Ma"ets
0este"n
u"oe
A and
/t!e"s
US +eneri!s, -'$
.ndian +eneri!s, 22$
/0, 11$
P. /thers, 13$
Sales(in s *illions)
S ene"ics
ndian ene"ics
%/0
A /t!e"s
A* *,, ) /(, >+-( 60, /(, , /(/ S7-(+), :/,+ 897)+)>
R6; =* )/* */+> -+,*,8, ) ,>+-()8 -+,*,8, : S7-(+,/(,+ )* =, )0,+*):), ) /,+
-
7/23/2019 A1 Strategic Memo Final
8/13
.e!t-E$uity Ratio '.1! '.'1 '.'1 '.'1 '.'1 '.'1
ROE '."# !.5% 23.32 22.32 1!.54 2".'4
RO*E '.13 #.3 23.3% 23.2# 1".3% 2".3"
I/ )* 8,+ :+< /(, 60, :)>7+,* /(/ /(,+, ROE )* 6,, +,78)> +,* :+ /()* 6,)>
/(, :8/o T(, ,8))> -+:)/* : R6; (* ) /(, ROE S7-(+
-
7/23/2019 A1 Strategic Memo Final
9/13
SUN PHARMATACTICS AND STRATEGY
Figure 4: Ta!ti!s and Strategy
S7-(+(,+ 6+>))> -=,+ 6 7/))@)> ()>(,+ ,8
-
7/23/2019 A1 Strategic Memo Final
10/13
S7 CEO MD D))- S(>(0) ( =+, /(/ *6 (, *7+8)>
R/7 B(7+) )+,8/+:)8, /(,+*.
M*/ *,)+ ,(/ ) :/,+ J-,*, >)/D))8() 67>(/ R6; :+< /(, S)>( 6+/(,+* ) 2''#.T(, -+6,< :+ /(, *,)+ R6;,;,87/)0,* 6,8)@/) =)/( )/* =-,-,.
T(, )/,>+/) -+8,** : S7 P(+
-
7/23/2019 A1 Strategic Memo Final
11/13
ARENA
K E;)*/)4>D,0,3.-,1>,4,+)86+.21-+.178/ 3)4,
DIFFERENTIATOR
K L.= C.*/
K S/+.4>1)*/+)67/).44,/=.+?
K R,3)263,OTC
K S/+.4>*-,8)23/5-+.178/*
STAGINGAND PACING
K I,A :.2 2 :.4 3 :.6
#e"in Ma"ets :.3 4 1.2 4 1.2ene"ic "o*t!otential :.3 3 :.9 2 :.6
T75TS
8
-
7/23/2019 A1 Strategic Memo Final
12/13
ove"n#ent"eulations :.1 4 :.4 2 :.2"oduct =ia&ility;lai# :.1 1 :.1 2 :.2;o#etitive=andscae 1 3 2.8
Sum --- -4
I /()* 8*, )0,+*):)> /(, -+78/* ) ,= 87/+),* *8+,* ()>(,+ /( /(, /,+/, */+/,>
/(/ )* 5.55 5.3. S =, 8(*, /(, :)+*/ */+/,> 0,+ /(, /,+/, */+/,>.
TARNISHED BRAND IMAGE ISSUE OF RANBAXY
R6; L6+/+),* /(, I) >,,+)8 +7>
-
7/23/2019 A1 Strategic Memo Final
13/13
FUTURE STRATEGY& REMEDIAL ACTIONS
T(, (0, 8(,;-, RD /,+/) )* )),* ,*7+)> 6 -+8/)8, 8GMP
++/) 8(+>,* ) +,+ / >,,+/, >/,+< *,+>),*
:+< /(, ,+ =)/( R6;. E6+/)> /(, 8GMP 8 /,+